MedCity News
SEPTEMBER 2, 2024
Many healthcare providers saw their revenues and operating margins grow in July, despite the fact that both labor and non-labor expenses continue to grow, according to new data. The post Hospitals’ Finances Are Getting Steadier, But Cost Pressures May Ruin That Soon appeared first on MedCity News.
Pharmaceutical Technology
SEPTEMBER 2, 2024
The US regulatory agency has also approved updated versions of Covid-19 vaccines from Moderna and Pfizer / BioNTech’s in the past two weeks.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MedCity News
SEPTEMBER 2, 2024
Despite the evidence of their positive impact, pharmacists today lack the ability to reliably bill for clinical services as healthcare providers. It is important that payers provision pharmacists, include them in networks, and enable reimbursement through traditional billing models. The post Pharmacists Embrace Provider Status in Healthcare, but Hurdles Remain appeared first on MedCity News.
Pharmaceutical Technology
SEPTEMBER 2, 2024
GLP-1RAs’ reduce CV risk, including reducing all-cause mortality and risk of MI, promoting weight loss and enhancing blood pressure control.
Advertisement
What if you could help your sellers stop wasting 72% of their day on non-selling activities and focus on bringing in revenue? Incorporating AI in your enablement workflows can help you cut down on busy work, get projects done faster, and let your team (and you!) focus on making a bigger impact. We put together this guide to show you how to use AI to cut time and costs for projects, including collateral creation, development of training videos, and automating tedious processes.
MedCity News
SEPTEMBER 2, 2024
A federal judge recently blocked the FTC’s ban on noncompetes. The decision has important implications for healthcare. The post A Federal Judge Struck Down FTC’s Ban on Noncompetes. What Does This Mean for Healthcare? appeared first on MedCity News.
Pharmaceutical Technology
SEPTEMBER 2, 2024
Aptose Biosciences has secured a loan of $10m through a facility agreement with Hanmi Pharmaceutical to develop tuspetinib.
Pharma Rep Focus brings together the best content for pharma rep professionals from the widest variety of industry thought leaders.
pharmaphorum
SEPTEMBER 2, 2024
UNICEF has issued an emergency tender to secure mpox vaccines for countries dealing with the brunt of the current outbreak
MedCity News
SEPTEMBER 2, 2024
As RNA biology and RNA therapeutics emerge in the mainstream of pharma, RNA foundation models offer massive potential for revolutionizing R&D. The post RNA Foundation Models to Improve Pharma R&D Productivity appeared first on MedCity News.
pharmaphorum
SEPTEMBER 2, 2024
Sanofi eyes filings for multiple sclerosis therapy tolebrutinib, although two of three phase 3 trials miss their primary endpoints
European Pharmaceutical Review
SEPTEMBER 2, 2024
Three anti-hypertensive drugs combined in low doses into a single pill has been shown to be superior to standard care for lowering blood pressure in patients with uncontrolled hypertension. The oral treatment GMRx2 is biopharma George Medicines’ lead drug candidate. The once-daily, three-in-one pill contains telmisartan, amlodipine and indapamide at a quarter, half or standard doses.
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
pharmaphorum
SEPTEMBER 2, 2024
iRhythm's Zio XT wearable heart monitor raises AFib diagnoses by 52%, but doesn't reduce stroke hospitalisations in GUARD-AF trial.
Pharmaceutical Technology
SEPTEMBER 2, 2024
Nxera will receive $35m from Neurocrine triggered by the successful completion of the Phase II trial of NBI-568 in schizophrenia.
pharmaphorum
SEPTEMBER 2, 2024
Biotech industry body BIA calls for new UK Chancellor Rachel Reeves to take sector-specific approach to R&D tax credits to tackle widespread fraud and abuse of the system.
Pharmaceutical Technology
SEPTEMBER 2, 2024
PHC Corporation has introduced a prototype of LiCellGrow, a cell expansion system designed to manufacture cell and gene therapy products.
Advertisement
Every marketer knows how important it is to prove their efforts drive sales opportunities, but that’s easier said than done. When problems like sales and marketing misalignment, lack of data, and wasted efforts persist, marketers can’t measure, prove, or increase their impact on revenue at a time when demonstrating marketing value is critical. Using analyst and expert data, this guide to marketing impact and content attribution explains: How B2B buyers use content The most common types of conten
Pharmaceutical Commerce
SEPTEMBER 2, 2024
The 8,000 square-foot facility—located within the wholesaler’s Le Vergne distribution center— is expected to help tackle cell and gene therapy logistical challenges.
PharmExec
SEPTEMBER 2, 2024
The insurance company is offering the guidance in response to continued popularity of the drugs which are commonly used for weight-loss management.
PharmaTech
SEPTEMBER 2, 2024
Updating your audits and inspections program ensures inspection preparedness, says Siegfried Schmitt, vice president, Technical at Parexel.
PharmExec
SEPTEMBER 2, 2024
OncLive serves as the connection to oncology, including groundbreaking cancer news and interviews with top oncologists in multimedia formats.
Pharmaceutical Technology
SEPTEMBER 2, 2024
New insights on the PACMAN-AMI trial for patients with acute myocardial infarction are presented at the ESC Congress, among other updates.
Pharmacy Times
SEPTEMBER 2, 2024
Cases have been detected in 33 US states so far this year, and the virus has recently hospitalized the former Chief Medical Advisor to the President of the US Anthony Fauci.
Pharmaceutical Technology
SEPTEMBER 2, 2024
The pharmaceutical industry is continuously evolving, driven by the imperative to develop more effective and personalized treatments.
Pharmacy Times
SEPTEMBER 2, 2024
For those with unexplained pregnancy loss, these results could prove promising improvements to birth outcomes.
Advertisement
Quotas need to be hit. Revenue goals need to be met. This reality makes shortening sales onboarding time a top priority. Organizations with a standard onboarding process boost employee retention by 58% and increase productivity by 50%. Unfortunately, many companies struggle with inefficient processes that lead to high turnover and missed revenue opportunities.
Pharmaceutical Technology
SEPTEMBER 2, 2024
Jacobio Pharma has out-licensed the China rights of its assets, glecirasib and JAB-3312, to Shanghai Allist Pharmaceuticals.
Pharmacy Times
SEPTEMBER 2, 2024
Robert Walker discusses the updated COVID-19 vaccines targeting the new JN.1 lineage of the virus and the challenges of addressing vaccine hesitancy to protect individuals and communities.
Pharmaceutical Technology
SEPTEMBER 2, 2024
A single-pill combination could present a better option for hypertension patients, said researchers at the ESC congress.
Pharmacy Times
SEPTEMBER 2, 2024
High-cost novel therapies challenge payers and patients, while biosimilars help balance affordability.
Pharmaceutical Technology
SEPTEMBER 2, 2024
Johnson & Johnson has selected Onco360 as a pharmacy partner for the distribution of LAZCLUZE (lazertinib).
Expert insights. Personalized for you.
107 
Let's personalize your content